APA (7th ed.) Citation

Patel, P. M., Ottensmeier, C. H., Mulatero, C., Lorigan, P., Plummer, R., Pandha, H. S., . . . Durrant, L. (2018). Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. Taylor & Francis.

Chicago Style (17th ed.) Citation

Patel, Poulam M., et al. Targeting Gp100 and TRP-2 with a DNA Vaccine: Incorporating T Cell Epitopes with a Human IgG1 Antibody Induces Potent T Cell Responses That Are Associated with Favourable Clinical Outcome in a Phase I/II Trial. Taylor & Francis, 2018.

MLA (9th ed.) Citation

Patel, Poulam M., et al. Targeting Gp100 and TRP-2 with a DNA Vaccine: Incorporating T Cell Epitopes with a Human IgG1 Antibody Induces Potent T Cell Responses That Are Associated with Favourable Clinical Outcome in a Phase I/II Trial. Taylor & Francis, 2018.